|
Volumn 8, Issue 9, 2005, Pages 704-707
|
Metabolic Diseases World Summit 2005. 29 June - 1 July 2005, San Francisco, CA, USA
a
BIOVITRUM AB
(Sweden)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
AT 1001;
ATORVASTATIN;
CS 917;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
ENZYME ACTIVATOR;
EXENDIN 4;
GC 1;
GLUCOKINASE;
GLYCOGEN SYNTHASE;
HORMONE RECEPTOR STIMULATING AGENT;
INSULIN;
INSULIN GLARGINE;
INSULIN LISPRO;
KB 141;
LISINOPRIL;
LOSARTAN;
METAGLIDASEN;
METFORMIN;
NATEGLINIDE;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;
PHX 1149;
PRAMLINTIDE;
RECOMBINANT HUMAN INSULIN;
RIMONABANT;
SITAGLIPTIN;
SULFONYLUREA DERIVATIVE;
TETRAHYDROISOQUINOLINE;
THYROID HORMONE RECEPTOR BETA;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VALSARTAN;
VILDAGLIPTIN;
ANTHROPOMETRY;
AREA UNDER THE CURVE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONSENSUS DEVELOPMENT;
DEMOGRAPHY;
DIABETES MELLITUS;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG SCREENING;
DRUG STRUCTURE;
DYSLIPIDEMIA;
ETHNOLOGY;
HEALTH CARE COST;
HEALTH CARE NEED;
HONG KONG;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
HYPOGLYCEMIA;
INCIDENCE;
METABOLIC DISORDER;
NOMENCLATURE;
NONHUMAN;
OBESITY;
RISK FACTOR;
SYMPTOMATOLOGY;
WAIST CIRCUMFERENCE;
AMYLOID;
ANIMALS;
ANTIGENS, CD26;
CHOLERA TOXIN;
HUMANS;
INSULIN;
METABOLIC DISEASES;
OBESITY;
PEPTIDES;
RECEPTORS, THYROID HORMONE;
VENOMS;
|
EID: 24644498165
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (1)
|
References (0)
|